Precision Medicine in Dermatology

The presentation discusses the role of precision medicine in the management of inflammatory skin diseases in dermatology. The speaker emphasizes the importance of understanding immune pathways, particularly those related to T cells, and how advancements in molecular technologies have facilitated the development of targeted therapies. Identified pathways, such as TH-1, TH-2, and TH-17, are linked to specific skin conditions like psoriasis, eczema, and lupus. The speaker advocates for a precision medicine approach that involves molecular profiling of skin samples to accurately diagnose and tailor treatment for patients. This involves using technologies like nano string for RNA profiling, allowing clinicians to navigate complex immune responses and determine the most effective therapy. The method has shown efficacy in diagnosing challenging cases and understanding shifts in immune profiles during treatment, which can lead to improved response rates. The application of this approach in a clinical setting has led to better treatment strategies, minimizing mismatches between therapies and patient profiles. The presentation concludes with an invitation to join a global network aimed at integrating these advancements in clinical practice.